Renaissance Technologies - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 67 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$6,757
-99.5%
452,000
+181.4%
0.01%
+350.0%
Q3 2022$1,322,000
+63.2%
160,600
+30.1%
0.00%
+100.0%
Q2 2022$810,000
+192.4%
123,400
+148.8%
0.00%
Q1 2022$277,000
-81.2%
49,600
-77.8%
0.00%
-100.0%
Q2 2021$1,475,000
+59.3%
223,870
+77.0%
0.00%
+100.0%
Q1 2021$926,000
+66.2%
126,495
+31.1%
0.00%0.0%
Q4 2020$557,000
+66.8%
96,500
+48.8%
0.00%
Q2 2020$334,00064,8680.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$22,809,0000.60%
SECTORAL ASSET MANAGEMENT INC 1,151,175$6,642,0000.47%
X-Square Capital, LLC 75,952$438,0000.24%
SABBY MANAGEMENT, LLC 68,092$393,0000.08%
WealthTrust Axiom LLC 22,347$128,0000.05%
Opaleye Management Inc. 58,800$339,0000.04%
Trexquant Investment LP 64,838$374,0000.04%
PDT Partners, LLC 60,117$347,0000.02%
PERSONAL CFO SOLUTIONS, LLC 13,000$75,0000.02%
CVI Holdings, LLC 13,171$76,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders